Amazon and General Catalyst Form AI-Centered Health Collaboration
- Business
- January 14, 2025
Amazon Web Services and General Catalyst have partnered on health-related artificial intelligence (AI).
According to AWS, the partnership, which was revealed on Monday, blends General Catalyst’s track record of healthcare investments with its technological know-how.
“AWS and General Catalyst believe that AI has immense potential to [effect] meaningful change in global health care,” AWS CEO Matt Garman said in a news release. “Together, we are taking bold steps to improve patient outcomes and make quality care more accessible to all by embedding AI throughout the care journey.”
To meet critical demands in interoperability, clinical and operational efficiency, diagnostics, patient engagement, and predictive and personalized care, the alliance will concentrate on developing and implementing AI-powered solutions, the release stated.
With plans to use Amazon Bedrock to harness the power of generative AI and collaborate with providers like Anthropic and Mistral AI, as well as securely trained health care-specific models, the firms stated that the potential is “vast.”
According to the release, “one example is the ability to drive more personalized health care by using disease-specific models that process diverse health data—such as genomic sequencing information, clinical trial data, radiology and pathology scans, and electronic health records—to help doctors and researchers spot patterns and diagnose, predict treatment outcomes, provide insights into disease progression, and more.”
PYMNTS CEO Karen Webster wrote on Monday on the relationship between generative AI (GenAI) and healthcare, imagining a future where “your doctor knows you’re getting sick before you do” and healthcare is more of a “proactive partnership” than a concern.
According to Webster, “GenAI has the potential to shift the conversation — and time and dollars spent — from how much it costs to make people well when they get sick to preventing illness beforehand.” In order to better understand and prevent disease, GenAI will be used in healthcare in the future. Smart technology will drive interactions with the patient, putting the patient first.
According to that analysis, the economics are “compelling,” as the predicted cost of healthcare in the United States is expected to reach $7.7 trillion by 2032, up from almost $5 trillion in 2023. Many consumers, particularly younger ones, claim that they will put off or forego medical care because they are unable to pay for it.
“That’s not just expensive — it’s unsustainable,” Webster wrote.
“By using intelligent monitoring devices and personalized health insights, it’s possible to dramatically reduce the cost of chronic disease management. Medication can be remotely prescribed, administered and monitored as appropriate, staving off a full-blown, expensive and potentially physically debilitating medical crisis.”